Literature DB >> 14741419

Interaction between HIV and intravenous heroin abuse?

Ian Paul Everall1.   

Abstract

In this article I will review the findings of the potential interactive effects of HIV infection and heroin use as observed in both clinical and laboratory studies. Some of the findings are discrepant and I will endeavour to propose models that could accommodate these variant results as well as suggest factors that could be considered in analysing future investigations in order to resolve these apparent discrepancies.

Entities:  

Mesh：

Year:  2004        PMID： 14741419     DOI： 10.1016/j.jneuroim.2003.10.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN： 0165-5728            Impact factor:   3.478


  9 in total

1.  Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia.

Authors:  Jadwiga Turchan-Cholewo; Filomena O Dimayuga; Qunxing Ding; Jeffrey N Keller; Kurt F Hauser; Pamela E Knapp; Annadora J Bruce-Keller
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

2.  Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation.

Authors:  Jadwiga Turchan-Cholewo; Filomena O Dimayuga; Sunita Gupta; Jeffrey N Keller; Pamela E Knapp; Kurt F Hauser; Annadora J Bruce-Keller
Journal:  J Neurochem       Date:  2008-11-19       Impact factor: 5.372

3.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

4.  HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.

Authors:  Nazira El-Hage; Guanghan Wu; Juan Wang; Jayakrishna Ambati; Pamela E Knapp; Janelle L Reed; Annadora J Bruce-Keller; Kurt F Hauser
Journal:  Glia       Date:  2006-01-15       Impact factor: 7.452

5.  Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.

Authors:  Nazira El-Hage; Julie A Gurwell; Indrapal N Singh; Pamela E Knapp; Avindra Nath; Kurt F Hauser
Journal:  Glia       Date:  2005-04-15       Impact factor: 7.452

6.  Neurometabolite abnormalities in simian immunodeficiency virus-infected macaques with chronic morphine administration.

Authors:  Christine C Cloak; Linda Chang; Shawn P O'Neil; Thomas M Ernst; Daniel C Anderson; Robert M Donahoe
Journal:  J Neuroimmune Pharmacol       Date:  2010-10-12       Impact factor: 4.147

Review 7.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

8.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

Review 9.  Opiate drug use and the pathophysiology of neuroAIDS.

Authors:  Kurt F Hauser; Sylvia Fitting; Seth M Dever; Elizabeth M Podhaizer; Pamela E Knapp
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.